CRVS
Corvus Pharmaceuticals Inc
12.50$
-6.7%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 100.0% | – | – | – | 100.0% | – | – | – | – | – | – | – | |
| – | 11.4% | – | – | – | 50.0% | – | – | – | – | – | – | – | |
| – | 88.6% | – | – | – | 50.0% | – | – | – | – | – | – | – | |
| – | 1,625.6% | – | – | – | 6,788.6% | – | – | – | – | – | – | – | |
| – | 671.5% | – | – | – | 2,421.6% | – | – | – | – | – | – | – | |
| – | 2,297.2% | – | – | – | 9,210.2% | – | – | – | – | – | – | – | |
| – | -2,297.2% | – | – | – | -9,210.2% | – | – | – | – | – | – | – | |
| – | 154.5% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -2,704.5% | – | – | – | -13,764.8% | – | – | – | – | – | – | – | |
| – | -38.6% | – | – | – | – | – | – | – | – | – | – | – | |
| – | -2,704.5% | – | – | – | -13,764.8% | – | – | – | – | – | – | – | |
| – | -2,693.1% | – | – | – | -13,742.0% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.